Science Friday10d
The FDA Approves A New, Non-Opioid Painkiller
Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...
FDA's approval of non-opioid pain pill could be game-changer
The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...
BioSpace4d
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
JD Supra8d
FDA Approved Journavx, a Non-Opioid Drug for Pain Management
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
pulmonologyadvisor9d
FDA Approves First New Non-Opioid Pain Pill in Decades
The US FDA has approved Journavx, a new pain reliever without the risks for addiction or overdose linked to drugs like Vicodin and OxyContin.
Study finds lack of consensus on how to treat chronic non-cancer pain
Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...
BioSpace10d
AlgoTx Stumbles in Non-Opioid Pain Trial Following Vertex’s Journavx Approval
AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...
GlobalData on MSN6d
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
Pharmaceutical Technology7d
GLP-1 receptor agonists could hold promise for opioid use disorder treatment
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...